|
As reflected in our Mission Statement, Najit Technologies is dedicated to the development of safe and effective vaccines for diseases that affect developing countries. Our goal is to develop products for diseases that affect large numbers of people in endemic countries. These diseases have not received adequate attention as demonstrated by the so-called "10/90" gap which describes the existing scenario wherein less than 10% of healthcare funding is spent on diseases that affect more than 90% of the world-wide disease burden (1). Although it appears that this gap is narrowing, there nevertheless continues to be a large discrepancy in healthcare spending between first and third world countries.
To address this need, Najit Technologies is developing vaccines for both endemic and newly emerging diseases that affect millions of people around the globe including West Nile virus, yellow fever, and dengue.
|
|
|
